PASCOE KEVIN CARLTON 4/A

What Happened Kevin Carlton Pascoe, Chief Investment Officer of National Health Investors (NHI), was awarded 4,726 shares on March 3, 2026. The Form 4/A shows the acquisition price as $0.00 (an awarded grant, not an open-market purchase), so the filing reports no cash paid for the shares. This filing is an amendment correcting an earlier overstatement — the previous report had overstated the award by 346 shares.

Key Details

• Transaction date: March 3, 2026; reported on Form 4/A filed March 30, 2026.
• Transaction type: Award/grant (code A); 4,726 shares acquired at $0.00 reported acquisition price (total $0 per filing).
• Footnote: F1 — original report overstated the award by 346 shares; this amended filing reports the corrected amount.
• Shares owned after the transaction: not specified in the provided excerpt of the filing.
• Filing status: This is an amended Form 4 (Form 4/A) to correct the previously reported amount.

Context Stock awards are typically compensation and do not represent an open-market purchase or sale; they reflect company compensation practices rather than a direct bullish or bearish trading signal. The amended filing simply corrects the number of shares awarded and should be viewed as an administrative correction rather than a change in trading behavior.